MYGNMYRIAD GENETICS INC

Nasdaq myriad.com


$ 22.94 $ -0.59 (-2.51 %)    

Wednesday, 21-Feb-2024 15:59:58 EST
QQQ $ 429.04 $ -1.71 (-0.4 %)
DIA $ 386.05 $ 0.36 (0.09 %)
SPY $ 499.20 $ 0.45 (0.09 %)
TLT $ 92.24 $ -0.66 (-0.71 %)
GLD $ 187.48 $ 0.01 (0.01 %)
$ 22.91
$ 23.20
$ 0.00 x 0
$ 0.00 x 0
$ 22.52 - $ 23.25
$ 13.82 - $ 24.21
517,098
na
1.88B
$ 1.39
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-07-2023 09-30-2023 10-Q
2 08-04-2023 06-30-2023 10-Q
3 05-04-2023 03-31-2023 10-Q
4 03-01-2023 12-31-2022 10-K
5 11-02-2022 09-30-2022 10-Q
6 08-05-2022 06-30-2022 10-Q
7 05-06-2022 03-31-2022 10-Q
8 02-25-2022 12-31-2021 10-K
9 11-04-2021 09-30-2021 10-Q
10 08-04-2021 06-30-2021 10-Q
11 05-05-2021 03-31-2021 10-Q
12 11-09-2020 09-30-2020 10-Q
13 08-13-2020 06-30-2020 10-K
14 05-06-2020 03-31-2020 10-Q
15 02-07-2020 12-31-2019 10-Q
16 11-06-2019 09-30-2019 10-Q
17 08-13-2019 06-30-2019 10-K
18 05-08-2019 03-31-2019 10-Q
19 02-06-2019 12-31-2018 10-Q
20 11-07-2018 09-30-2018 10-Q
21 08-24-2018 06-30-2018 10-K
22 05-09-2018 03-31-2018 10-Q
23 02-07-2018 12-31-2017 10-Q
24 11-08-2017 09-30-2017 10-Q
25 08-09-2017 06-30-2017 10-K
26 05-03-2017 03-31-2017 10-Q
27 02-08-2017 12-31-2016 10-Q
28 11-02-2016 09-30-2016 10-Q
29 08-10-2016 06-30-2016 10-K
30 05-04-2016 03-31-2016 10-Q
31 02-03-2016 12-31-2015 10-Q
32 11-04-2015 09-30-2015 10-Q
33 08-12-2015 06-30-2015 10-K
34 05-06-2015 03-31-2015 10-Q
35 02-04-2015 12-31-2014 10-Q
36 11-05-2014 09-30-2014 10-Q
37 08-13-2014 06-30-2014 10-K
38 05-07-2014 03-31-2014 10-Q
39 02-05-2014 12-31-2013 10-Q
40 11-12-2013 09-30-2013 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 goldman-sachs-maintains-buy-on-myriad-genetics-raises-price-target-to-31

Goldman Sachs analyst Matthew Sykes maintains Myriad Genetics (NASDAQ:MYGN) with a Buy and raises the price target from $28 ...

 goldman-sachs-maintains-buy-on-myriad-genetics-raises-price-target-to-31

Goldman Sachs analyst Matthew Sykes maintains Myriad Genetics (NASDAQ:MYGN) with a Buy and raises the price target from $28 ...

 myriad-genetics-acquires-precise-tumor-precise-liquid-and-laboratory-from-intermountain-precision-genomics-deal-terms-not-disclosed

"With this acquisition, we're deepening our commitment to our oncology business while also generating a more effective ...

 genetic-testing-pioneer-myriad-genetics-evolution-draws-analyst-attention-amid-new-products-anticipation

Piper Sandler initiated coverage on Myriad Genetics Inc (NASDAQ: MYGN), noting that many investors know the company as one of t...

 piper-sandler-initiates-coverage-on-myriad-genetics-with-neutral-rating-announces-price-target-of-23

Piper Sandler analyst John Peterson initiates coverage on Myriad Genetics (NASDAQ:MYGN) with a Neutral rating and announces ...

 myriad-genetics-establishes-comprehensive-pan-cancer-research-platform-to-advance-patient-care

Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in genetic testing and precision medicine, today announced the launch of the Myri...

 wells-fargo-initiates-coverage-on-myriad-genetics-with-equal-weight-rating-announces-price-target-of-20

Wells Fargo analyst Timothy Daley initiates coverage on Myriad Genetics (NASDAQ:MYGN) with a Equal-Weight rating and announc...

 guggenheim-initiates-coverage-on-myriad-genetics-with-buy-rating-announces-price-target-of-23

Guggenheim analyst Subbu Nambi initiates coverage on Myriad Genetics (NASDAQ:MYGN) with a Buy rating and announces Price Tar...

 wolfe-research-initiates-coverage-on-myriad-genetics-with-outperform-rating

Wolfe Research analyst Doug Schenkel initiates coverage on Myriad Genetics (NASDAQ:MYGN) with a Outperform rating.

 myriad-genetics-celebrates-one-million-sneakpeek-results-shared-with-expectant-parents

Myriad Genetics, Inc., (NASDAQ:MYGN), a leader in genetic testing and precision medicine, today announced it has delivered resu...

 why-amc-entertainment-shares-are-trading-lower-by-around-14-here-are-other-stocks-moving-in-thursdays-mid-day-session

Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results.

 aersale-topgolf-callaway-brands-digital-turbine-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session

U.S. stock futures traded mostly higher this morning on Thursday. Here are some big stocks recording losses in today’s pre-mark...

 jp-morgan-maintains-underweight-on-myriad-genetics-lowers-price-target-to-14

JP Morgan analyst Rachel Vatnsdal maintains Myriad Genetics (NASDAQ:MYGN) with a Underweight and lowers the price target fro...

 why-sanmina-shares-are-trading-lower-by-around-15-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spe...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION